Login / Signup

Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.

Yannick D MullerNseir GhalebSamuel RotmanJulien VionnetMatthieu HalfonEmmanuelle CatanaDéla GolshayanJean-Pierre VenetzVincent AubertManuel Pascual
Published in: Transplant international : official journal of the European Society for Organ Transplantation (2018)
Keyphrases
  • combination therapy
  • diffuse large b cell lymphoma
  • open label
  • randomized controlled trial
  • hodgkin lymphoma
  • replacement therapy
  • study protocol
  • smoking cessation